A naukri.com initiative
Bloomberg Quint
1w
124
Image Credit: Bloomberg Quint
Granules Recalls 33,000 Bottles Of Blood Lowering Medication In US
- Granules India is recalling over 33,000 bottles of Metoprolol Succinate extended-release tablets in the US due to failed dissolution specifications.
- The recall was initiated by the US-based Granules Pharmaceuticals Inc because the product failed to meet dissolution acceptance criteria in stability studies at the sixth month.
- The recall is categorized as Class II by the USFDA, indicating that the use of the violative product may lead to temporary or medically reversible health consequences.
- Shares of Granules India were trading 0.54% down following the announcement of the recall.
Read Full Article
6 Likes
For uninterrupted reading, download the app